Literature DB >> 6404329

The origin of human NK cells. An ontogenic model derived from studies in patients with immunodeficiencies.

H H Peter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6404329     DOI： 10.1007/BF00319864

Source DB:  PubMed          Journal:  Blut        ISSN： 0006-5242


× No keyword cloud information.
  37 in total

1.  Natural killer cell activity and preleukaemia.

Authors:  S Takaku; F Takaku
Journal:  Lancet       Date:  1981-11-21       Impact factor: 79.321

2.  Large granular lymphocytes in human peripheral blood: ultrastructural and cytochemical characterization of the granules.

Authors:  C E Grossi; A Cadoni; A Zicca; A Leprini; M Ferrarini
Journal:  Blood       Date:  1982-02       Impact factor: 22.113

3.  Heterogeneity of lymphocyte subpopulations in severe combined immunodeficiency. Evidence against a stem cell defect.

Authors:  R H Buckley; R B Gilbertsen; R I Schiff; E Ferreira; S O Sanal; T A Waldmann
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

4.  [Effector function of acute leukemias in "spontaneous" (SCMC) and antibody dependent cellular cytotoxicity-tests (ADCC) (author's transl)].

Authors:  P Schmidt; H H Peter; J R Kalden; H J Avenarius; H Bodenstein
Journal:  Klin Wochenschr       Date:  1978-10-01

5.  Surface markers on human b and t lymphocytes. VI. Cytotoxicity against cell lines as a functional marker for lymphocyte subpopulations.

Authors:  M Jondal; H Pross
Journal:  Int J Cancer       Date:  1975-04-15       Impact factor: 7.396

6.  Functional and developmental compartments of human T lymphocytes.

Authors:  P C Kung; G Goldstein
Journal:  Vox Sang       Date:  1980-09       Impact factor: 2.144

7.  Humoral and cellular immune reactions 'in vitro' against allogeneic and autologous human melanoma cells.

Authors:  H H Peter; J R Kalden; P Seeland; V Diehl; G Eckert
Journal:  Clin Exp Immunol       Date:  1975-05       Impact factor: 4.330

8.  A glycolipid on the surface of mouse natural killer cells.

Authors:  M Kasai; M Iwamori; Y Nagai; K Okumura; T Tada
Journal:  Eur J Immunol       Date:  1980-03       Impact factor: 5.532

9.  Natural killer and killer cell activities in patients with primary immunodeficiencies or defects in immune interferon production.

Authors:  M Lipinski; J L Virelizier; T Tursz; C Griscelli
Journal:  Eur J Immunol       Date:  1980-04       Impact factor: 5.532

10.  Natural killing in immunodeficient patients.

Authors:  H S Koren; D B Amos; R H Buckley
Journal:  J Immunol       Date:  1978-03       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.